Neuren Shares Rise, CSL Inches Down After Trump Flags Tariffs on Pharmaceuticals

MT Newswires Live
07/09

Shares of Neuren Pharmaceuticals (ASX:NEU) rose almost 1% in early trading on Wednesday, while those of CSL (ASX:CSL) were marginally lower, following US President Donald Trump's remarks on tariffs on the pharmaceutical industry on Tuesday.

Trump threatened to impose up to 200% tariffs on pharmaceuticals imported into the US "very soon," adding that he will "give people about a year, year and a half," CNBC reported.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10